Cell-free and cell-based approaches for bone regeneration
- 10 November 2009
- journal article
- review article
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 5 (12), 685-697
- https://doi.org/10.1038/nrrheum.2009.228
Abstract
The clinical augmentation of bone currently involves the use of autogenous or allogeneic bone grafts and synthetic materials, all of which are associated with limitations. Research on the safe enhancement of bone formation concerns the potential value of scaffolds, stem cells, gene therapy, and chemical and mechanical signals. Optimal scaffolds are engineered to provide mechanical stability while supporting osteogenesis, osteoconduction and/or osteoinduction. Scaffold materials include natural or synthetic polymers, ceramics, and composites. The resorption, mechanical strength and efficacy of these materials can be manipulated through structural and chemical design parameters. Cell-seeded scaffolds contain stem cells or progenitor cells, such as culture-expanded marrow stromal cells and multipotent skeletal progenitor cells sourced from other tissues. Despite extensive evidence from proof-of-principle studies, bone tissue engineering has not translated to clinical practice. Much of the research involves in vitro and animal models that do not replicate potential clinical applications. Problem areas include cell sources and numbers, over-reliance on existing scaffold materials, optimum delivery of factors, control of transgene expression, vascularization, integration with host bone, and the capacity to form bone and marrow structures in vivo. Current thinking re-emphasizes the potential of biomimetic materials to stimulate, enhance, or control bone's innate regenerative capacity at the implantation site.Keywords
This publication has 133 references indexed in Scilit:
- Orthopedic Gene Therapy in 2008Molecular Therapy, 2009
- A High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem CellsCell Stem Cell, 2008
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect modelBone, 2008
- The effect of RGD peptides on osseointegration of hydroxyapatite biomaterialsBiomaterials, 2008
- Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusionInternational Orthopaedics, 2007
- A tissue engineering approach to bone repair in large animal models and in clinical practiceBiomaterials, 2007
- Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defectsGene Therapy, 2007
- Recombinant human bone morphogenetic protein-2 and collagen for bone regenerationJournal of Biomedical Materials Research, 1998
- Recombinant human bone morphogenetic protein‐2 is superior to demineralized bone matrix in repairing craniotomy defects in ratsJournal of Biomedical Materials Research, 1994